Erlotinib Terminated Phase 2 Trials for Stage IIA Non-small Cell Lung Cancer / Stage IIIA Non-Small Cell Lung Cancer / Stage IB Non-small Cell Lung Cancer / Stage IA Non-small Cell Lung Cancer / Stage IIB Non-small Cell Lung Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00087269Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical Resection